Publication:
Successful Medical Management of Life-threatening Hepatic Hemangioma in Neonates

dc.contributor.authorRamrada Lekwuttikarnen_US
dc.contributor.authorShellie Josephsen_US
dc.contributor.authorJoyce M. Tengen_US
dc.contributor.otherStanford University School of Medicineen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T10:33:55Z
dc.date.available2020-01-27T10:33:55Z
dc.date.issued2019-01-01en_US
dc.description.abstractCopyright © 2019 by the American Academy of Pediatrics Hepatic hemangioma (HH) is a common asymptomatic, self-limiting benign vascular tumor of the liver in neonates. Although complicated HHs are rare, they have significant risks of morbidity and mortality, especially during the perinatal period. Because of the high risks of complications from surgical interventions, there is an unmet need for effective medical therapy. We report 2 neonates with life-threatening HH who were evaluated for a liver transplant before being treated successfully with combined medical therapy, which included sirolimus, corticosteroids, and propranolol.en_US
dc.identifier.citationPediatrics. Vol.144, No.4 (2019)en_US
dc.identifier.doi10.1542/peds.2019-1339en_US
dc.identifier.issn10984275en_US
dc.identifier.issn00314005en_US
dc.identifier.other2-s2.0-85072848773en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/52307
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072848773&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleSuccessful Medical Management of Life-threatening Hepatic Hemangioma in Neonatesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072848773&origin=inwarden_US

Files

Collections